Tissue Repair Ltd (TRP.AX)
AUD 0.2
(0.0%)
AUD 0.2
(0.0%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 | -4.13 Million AUD | 0.87% |
| 2023 | -4.17 Million AUD | 38.95% |
| 2022 | -6.83 Million AUD | -647.09% |
| 2021 | -915.22 Thousand AUD | -159.85% |
| 2020 | -352.21 Thousand AUD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q4 | -940.54 Thousand AUD | 0.0% |
| 2024 Q2 | -2.25 Million AUD | -100.0% |
| 2024 Q1 | -1.12 Million AUD | -10.61% |
| 2024 FY | -4.13 Million AUD | 0.87% |
| 2024 Q3 | -940.54 Thousand AUD | 58.33% |
| 2023 Q1 | -1.57 Million AUD | 17.91% |
| 2023 FY | -4.17 Million AUD | 38.95% |
| 2023 Q4 | -1.02 Million AUD | -100.0% |
| 2023 Q3 | -510.11 Thousand AUD | 83.83% |
| 2023 Q2 | -3.15 Million AUD | -100.0% |
| 2022 FY | -6.83 Million AUD | -647.09% |
| 2022 Q4 | -1.92 Million AUD | -100.0% |
| 2022 Q3 | -960.63 Thousand AUD | 80.46% |
| 2022 Q2 | -4.91 Million AUD | -100.0% |
| 2022 Q1 | -2.45 Million AUD | -600.52% |
| 2021 Q1 | -106.7 Thousand AUD | 0.0% |
| 2021 FY | -915.22 Thousand AUD | -159.85% |
| 2021 Q4 | -350.9 Thousand AUD | 0.0% |
| 2021 Q3 | -350.9 Thousand AUD | -228.85% |
| 2021 Q2 | -106.7 Thousand AUD | 0.0% |
| 2020 FY | -352.21 Thousand AUD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| AdAlta Limited | -5.38 Million AUD | 23.102% |
| Acrux Limited | -5.8 Million AUD | 28.653% |
| Actinogen Medical Limited | -13.04 Million AUD | 68.276% |
| AnteoTech Limited | -8.88 Million AUD | 53.402% |
| Argenica Therapeutics Limited | -5.47 Million AUD | 24.48% |
| Arovella Therapeutics Limited | -8.74 Million AUD | 52.686% |
| Anatara Lifesciences Ltd | -1.45 Million AUD | -185.142% |
| Alterity Therapeutics Limited | -19.12 Million AUD | 78.361% |
| Amplia Therapeutics Limited | -4.5 Million AUD | 8.113% |
| Avecho Biotechnology Limited | -3.43 Million AUD | -20.414% |
| Bio-Gene Technology Limited | -2.4 Million AUD | -71.764% |
| Biome Australia Limited | -1.67 Million AUD | -147.761% |
| Biotron Limited | -3.43 Million AUD | -20.415% |
| Botanix Pharmaceuticals Limited | -13.86 Million AUD | 70.164% |
| BTC Health Limited | 1.05 Million AUD | 492.131% |
| Chimeric Therapeutics Limited | -12.52 Million AUD | 66.974% |
| CSL Limited | 2.64 Billion AUD | 100.157% |
| Clarity Pharmaceuticals Ltd | -42.32 Million AUD | 90.223% |
| Clinuvel Pharmaceuticals Limited | 35.63 Million AUD | 111.612% |
| Cynata Therapeutics Limited | -9.74 Million AUD | 57.535% |
| Dimerix Limited | -17.07 Million AUD | 75.765% |
| EZZ Life Science Holdings Limited | 6.96 Million AUD | 159.417% |
| Hexima Limited | -933.87 Thousand AUD | -343.112% |
| Island Pharmaceuticals Limited | -2.86 Million AUD | -44.471% |
| Immuron Limited | -6.93 Million AUD | 40.347% |
| Immutep Limited | -39.89 Million AUD | 89.628% |
| Imugene Limited | -149.68 Million AUD | 97.235% |
| Invex Therapeutics Ltd | -1.64 Million AUD | -152.045% |
| Memphasys Limited | -4.44 Million AUD | 6.842% |
| Nanollose Limited | -1.15 Million AUD | -257.796% |
| Neuren Pharmaceuticals Limited | 157.08 Million AUD | 102.634% |
| Noxopharm Limited | -3.57 Million AUD | -15.65% |
| NeuroScientific Biopharmaceuticals Limited | 324.21 Thousand AUD | 1376.365% |
| Nyrada Inc. | -1.38 Million AUD | -198.516% |
| Orthocell Limited | -7.18 Million AUD | 42.374% |
| PharmAust Limited | -9.03 Million AUD | 54.186% |
| Patrys Limited | -3.53 Million AUD | -16.924% |
| Paradigm Biopharmaceuticals Limited | -58.65 Million AUD | 92.945% |
| Proteomics International Laboratories Limited | -6.37 Million AUD | 35.101% |
| Prescient Therapeutics Limited | -8.23 Million AUD | 49.768% |
| PYC Therapeutics Limited | -37.72 Million AUD | 89.031% |
| Race Oncology Limited | -13.81 Million AUD | 70.056% |
| Radiopharm Theranostics Limited | -47.94 Million AUD | 91.37% |
| Recce Pharmaceuticals Ltd | -17.66 Million AUD | 76.57% |
| Starpharma Holdings Limited | -8.16 Million AUD | 49.319% |
| Telix Pharmaceuticals Limited | 5.21 Million AUD | 179.411% |
| Zelira Therapeutics Limited | -36.56 Million AUD | 88.684% |